⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
RXRX News
Recursion Pharmaceuticals, Inc. Class A Common Stock
Recursion Reports Grant of Inducement Awards as Permitted by the Nasdaq Listing Rules
globenewswire.com
RXRX
AI, Genomics, and CRISPR Signal a New Phase of Biological Innovation
globenewswire.com
ILMN
GH
RXRX
AI-Driven Bioengineering Platforms Revolutionize Protein, Strain, and Drug Design with Multi-Billion Dollar Government Support
globenewswire.com
DNA
RXRX
AI-Native Data Core Triggers Multi-Trillion Dollar Healthcare Structural Shift
prnewswire.com
SDGR
RXRX
TEM
LLY
Aurora Therapeutics Launches to Realize Potential of Personalized Gene Editing for Millions of Patients with Rare Diseases
businesswire.com
GILD
RXRX
Artificial Intelligence in Drug Repurposing Global Market Research Report 2025 with Long-term Prospects to 2029 and 2034
globenewswire.com
IBM
EVGN
DNA
RXRX
COSM
Recursion to Present at 44th Annual J.P. Morgan Healthcare Conference
globenewswire.com
RXRX
Menlo Ventures Announces Promotion of Deborah Carrillo to Partner
globenewswire.com
ROKU
UBER
RXRX
Platform Technologies Drive $211B Surge in Precision Cancer Treatment
prnewswire.com
GTBP
ERAS
FHTX
OABI
RXRX
Positive Phase 1b/2 Results from Ongoing REC-4881 TUPELO Trial Demonstrate Rapid and Durable Reductions in Polyp Burden in Familial Adenomatous Polyposis (FAP) at 25 Weeks
globenewswire.com
RXRX